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Abstract 
Background: The infectious agent responsible for the bovine spongiform encephalopathy (BSE) epidemic in Great 
Britain is a transmissible spongiform encephalopathy (TSE) strain with uniform properties but the origin of this strain 
remains unknown. Based on the hypothesis that classical BSE may have been caused by a TSE strain present in sheep, 
cattle were inoculated intracerebrally with two different pools of brains from scrapie‑affected sheep sourced prior 
to and during the BSE epidemic to investigate resulting disease phenotypes and characterise their causal agents by 
transmission to rodents.
Results: As reported in 2006, intracerebral inoculation of cattle with pre‑1975 and post‑1990 scrapie brain pools 
produced two distinct disease phenotypes, which were unlike classical BSE. Subsequent to that report none of the 
remaining cattle, culled at 10 years post inoculation, developed a TSE. Retrospective Western immunoblot examina‑
tion of the brains from TSE cases inoculated with the pre‑1975 scrapie pool revealed a molecular profile similar to 
L‑type BSE. The inoculation of transgenic mice expressing the bovine, ovine, porcine, murine or human prion protein 
gene and bank voles with brains from scrapie‑affected cattle did not detect classical or atypical BSE strains but identi‑
fied two previously characterised scrapie strains of sheep.
Conclusions: Characterisation of the causal agents of disease resulting from exposure of cattle to naturally occurring 
scrapie agents sourced in Great Britain did not reveal evidence of classical or atypical BSE, but did identify two distinct 
previously recognised strains of scrapie. Although scrapie was still recognizable upon cattle passage there were irrec‑
oncilable discrepancies between the results of biological strain typing approaches and molecular profiling methods, 
suggesting that the latter may not be appropriate for the identification and differentiation of atypical, particularly 
L‑type, BSE agents from cattle experimentally infected with a potential mixture of classical scrapie strains from sheep 
sources.
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Background
Epidemiological studies indicated that the bovine spongi-
form encephalopathy (BSE) epidemic in the United King-
dom (UK) was caused by food-borne exposure of cattle 
to a transmissible spongiform encephalopathy (TSE) 
agent [1], but the origin of that agent remains unknown. 
As previously summarised [2], the initial characterisation 
of the agent isolated from cattle, and from several mam-
malian species to which BSE was subsequently transmit-
ted, naturally and experimentally, concluded that it was 
a single, unique strain of TSE agent unlike that of previ-
ously identified strains of scrapie of sheep [3–5]. Nev-
ertheless, sheep scrapie was considered a source of TSE 
agents to which cattle were potentially exposed via com-
mercial feed. Notwithstanding the possible modification 
of agents resulting from commercial feed processing, a 
study was initiated in 1997 to assess the pathogenicity 
of scrapie agents for cattle. By inoculating cattle intrac-
erebrally with two pools of brains from classical scrapie-
affected sheep sourced in Great Britain (GB) before and 
during the BSE epidemic this study could potentially 
identify an endemic form of scrapie that was pathogenic 
for cattle or a BSE agent present in the sheep population. 
Interim results published in 2006 identified two differ-
ent disease phenotypes, neither of which were consistent 
with the then recognised stereotypic phenotype of BSE 
in cattle and isolates from these did not have the strain 
typing characteristics of the BSE agent on transmission 
to wild-type mice [2]. The present manuscript describes 
updated findings of the cattle transmission study follow-
ing cull of all cattle remaining at 10  year post inocula-
tion and includes further characterisation of the disease 
occurring in recipients using newly available molecular 
diagnostic and biological strain typing techniques.
Subsequent to the initiation of the study, two differ-
ent disease phenotypes of naturally occurring BSE were 
described, termed H-type [6] and bovine amyloidotic 
spongiform encephalopathy (BASE) or L-type BSE [7]. 
Later research suggested that these ‘atypical’ BSE forms 
arise spontaneously in cattle and may have been the ori-
gin of the agent responsible for the BSE epidemic, termed 
now ‘classical’ or ‘C-type’ BSE [8, 9]. To aid in the differ-
entiation of these atypical forms of BSE from classical 
BSE, a new postmortem test protocol was proposed for 
the molecular discrimination of isolates [10]. It was these 
advances and the availability of new transmission mod-
els that were used to improve characterisation of isolates 
from the initial study. The transmission models included 
the use of bank voles, which are particularly susceptible 
to certain ovine scrapie strains [11], even from sources 
that are poorly or not transmissible to conventional and 
transgenic mice [12]. Transgenic mice expressing the 
ovine [13] or bovine prion protein (PrP) gene [14] were 
also used to facilitate transmissibility of ovine and bovine 
derived TSEs respectively.
Methods
All procedures were carried out following ethical review 
in the authors’ respective institutions and in accord-
ance with the European (European Community Council 
Directive 86/609/EEC) and the following national legisla-
tion: Home Office approval under the Animal (Scientific 
Procedures) Act 1986 and relevant project licences in 
the UK; Italian Ministry of Health authorisation accord-
ing to Legislative Decree 116/92; agreement numbers 
02-032-02 for animal care facilities, 92–189 for animal 
experimentation in France and the Committee on the 
Ethics of Animal Experiments of the INIA (Permit Num-
bers: M03043 and CEEA2O12/O24) approval in Spain. In 
each of the following sections the biological strain typing 
and WB profiling methods applied for phenotypic char-
acterization are described in relation to the host models 
utilised.
Transmission of scrapie to cattle
The methods of this study were presented in detail previ-
ously and Additional file 1 summarises the experimental 
design and outcomes [2].
Briefly, two groups of cattle were inoculated intrac-
erebrally with brain homogenate from pathologically 
confirmed scrapie cases sourced prior to 1975 (ten cat-
tle) and after 1990 (ten cattle). Both inocula were char-
acterised by biochemical (Western immunoblot (WB) 
hybrid technique [15]) and biological (transmission in 
C57Bl, RIII and VM mice) approaches, which suggested 
that both contained classical scrapie isolates. Controls 
comprised five cattle inoculated intracerebrally with 
New Zealand-derived ovine brain homogenate [with no 
detectable disease-associated prion protein (PrPSc) in 
the brain] and five cattle inoculated intracerebrally with 
saline solution. The study was terminated at 120 months 
post inoculation (mpi), and all remaining cattle (one 
from the pre-1975 group, three from the post-1990 
group and controls) were euthanased with pentobar-
bitone. Pathological examinations were carried out as 
described previously [2]. The WB protocol used formerly 
was modified and applied retrospectively to previously 
positive samples. The modified protocol was based on 
the BioRad TESeE WB method (BioRad Laboratories, 
Marnes-La-Coquette, France) using mAb Sha31 (BioRad 
Laboratories) in place of the previously used mAb 6H4 
(Prionics AG, Schlieren, Switzerland) and mAb P4 (Biop-
harm, Darmstadt, Germany) [16]. These mAbs target the 
PrP amino acid (aa) residues 156–163 (Sha31), aa 155–
163 (6H4), and aa 97–112 (P4) of the sheep PrP sequence. 
In addition, mAb SAF84 (bovine aa sequence 175–180, 
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kindly supplied by Dr. T Baron, AFSSA, France) was used 
because of its particular usefulness in identifying H-type 
BSE by specific downward molecular mass shift [17] and 
the potential to discriminate between CH1641-like scra-
pie and L-type BSE in ovine transgenic mice [18].
With this WB technique proteinase-resistant prion 
protein (PrPres) is detected as three protein bands that 
relate to diglycosylated, monoglycosylated and unglyco-
sylated forms of the abnormal protein, and the migration 
as well as the relative intensity (expressed as glycoform 
ratio) of the protein bands of PrPres enables differentia-
tion of scrapie from BSE. Discrimination is also possi-
ble by parallel testing with the two specific mAbs: mAb 
Sha31 detects PrPres in both cattle and sheep, while mAb 
P4 is more selective for scrapie PrPres under the test con-
ditions, as reported previously [15]. All positive samples 
were subjected to mild and stringent proteinase K (PK) 
digestion [10, 19] and the blotted PrPres bands detected 
using mAbs Sha31, 6H4 and P4. Stringent digestion was 
undertaken with 500 μg/ml PK at pH 8.0, and mild diges-
tion with 50 μg/ml PK at pH 6.5. The PK susceptibility 
ratio was obtained by comparing the optical density of 
the signal strengths of the PrPres bands produced by mild 
and stringent digestion, which is >0.7 for C-type BSE and 
<0.6 for L-type BSE cases [10, 19].
Determination of the bovine PrP gene of the cattle was 
repeated for the purpose of this update to better deter-
mine potential genetic susceptibility factors influencing 
the outcome of transmissions and included examina-
tion of the promoter region and full open reading frame 
(ORF) from either blood (live animal) or brain (culled 
animal) according to methods described previously [20].
The original study design included strain characteri-
sation only in wild-type mice but brain tissue was sub-
sequently distributed to other research institutes to 
further characterise bovine passaged scrapie in additional 
rodent lines. This was carried out independent of the 
original study and selection of material was restricted by 
availability.
Transmissions in bank voles
Bank voles (Myodes glareolus) were inoculated with 
brain tissue (parietal cortex) from steers P75-7  (inocu-
lated with the pre-1975 pool) and P90-4 (inoculated with 
the post-1990 pool), both positive for PrPSc in brain. 
Both inocula were further tested by WB for presence of 
PrPres as described previously using mAb SAF84 (Bertin 
Pharma, Montigny le Bretonneux, France) and mAb P4 
(Biopharm, Milan, Italy) [21].
Each of two groups of 15 bank voles (homozygous for 
methionine at codon 109 of the PrP gene) were inocu-
lated with 20  μl of brain homogenate (as 10% w/v in 
PBS) derived from each of the two steers. Inoculation 
procedure, clinical monitoring and euthanasia at terminal 
stage of disease were as described previously [12]. Brains 
from individual voles culled at terminal stage of disease 
were used for subsequent passages using the same proto-
col. Individual vole brains were used for strain typing by 
biochemical PrPres characterisation and lesion profiling. 
Brains were examined by WB with mAb SAF84 targeting 
PrP aa residues 163–173 of the bank vole PrP sequence 
and 12B2 (CVI, Lelystad, Netherlands; PrP aa residues 
89–93 of the sheep PrP sequence) [22], and lesion pro-
files were carried out by scoring vacuolar changes in nine 
grey matter areas of the brain on H&E stained sections 
[12].
The disease phenotypes observed in voles after trans-
mission of P75-7 and P90-4 brain samples were com-
pared with those previously derived from different 
scrapie sources, including natural ovine scrapie isolates 
SS-UK6 (10 brains) and SCR6 (single brain) [12] and 
the experimental CH1641 isolate (kindly provided by N. 
Hunter, Roslin Institute, University of Edinburgh, UK).
Transmissions in transgenic mice
Inocula comprised the original two scrapie brain pools 
(pre-1975 and post-1990) and brain tissue (thalamus, 
with detectable PrPSc) from the clinically affected steers 
P75-7 (as above) and P90-1  (inoculated with the post-
1990 pool). Both of the original inocula and the brain of 
steer P90-1 had previously been inoculated into conven-
tional mice (RIII, C57Bl and VM), resulting in successful 
transmission with lesion profile features uncharacteristic 
of BSE (pre-1975 pool), or transmissions with low attack 
rates, insufficient to establish a lesion profile in RIII mice 
(post-1990 pool and P90-1) [2]; see also Additional file 1 
for a summary.
Inoculations were carried out in transgenic mouse lines 
expressing the PrP gene of various species as follows: 
tg338 mice (expressing the VRQ allele of the ovine PrP 
gene [23]), tg110 (expressing the bovine PrP gene [14]), 
tg001 (expressing the porcine PrP gene [24]), tga20 (over-
expressing the murine PrP gene [25]) and tg340 (over-
expressing the M129 allele of the human PrP gene [26]).
Groups of 6–12 mice were inoculated intracerebrally 
with 20 μl of either 2% homogenate of the original ovine 
brain pools or 10% homogenate of the bovine brain tis-
sue (prepared in sterile 5% glucose). The former inocu-
lum dilution was determined by restricted availability 
of source tissue. The procedures for inoculation, clinical 
monitoring and cull of affected mice were as described 
previously [9].
Disease in mice was confirmed according to previously 
published protocols for detection of PrPres by WB with 
mAb Sha31 (BioRad Laboratories) [9] or paraffin embed-
ded tissue blot (PET blot), which uses mAb Sha31 (BioRad 
Page 4 of 14Konold et al. BMC Res Notes  (2015) 8:312 
Laboratories), followed by the application of an alkaline 
phosphatase coupled secondary antibody (Dako reference 
D0314—1/500 diluted, Dako France S.A.S, Les Ulis Cedex) 
and detection of enzymatic activity using NBT/BCIP sub-
strate chromogen [27]. Brain homogenates from PrPres posi-
tive mice, where available, were used for further passages. 
When, on primary passage, all mice of an inoculum group 
were negative for PrPres a second passage of the pooled 
brain homogenates was carried out. For second passages, 
mice were inoculated intracerebrally with 20 μl of a 10% w/v 
brain homogenates (prepared in sterile 5% glucose).
Data were compared to those derived from mice inocu-
lated with classical BSE bovine and ovine brain homoge-
nates and with L-type and H-type BSE bovine brain 
homogenates, some of which were obtained from sepa-
rate studies [9, 26, 28–31].
Results and discussion
Transmissions of scrapie to cattle
From the time of publication of interim results [2] to 
termination of the study, no additional cases of TSE, as 
confirmed by postmortem tests, were identified in the 
remaining cattle inoculated with the two scrapie pools. 
Thus, the attack rate remained at 9/10 in cattle inocu-
lated with the pre-1975 pool and 7/10 in cattle inoculated 
with the post-1990 pool, with affected cattle presenting 
either with a clinical “nervous” syndrome (see Additional 
file  2: nervous form) or “dull” syndrome (see Additional 
file  3: dull form). Details of all cattle, with time and cir-
cumstances of death, clinical signs and diagnosis are 
presented in Table 1. Two of the three cattle (P90-8 and 
P90-9) receiving the post-1990 scrapie pool and surviving 
to termination, displayed some clinical signs similar to the 
previous seven pathologically confirmed cases within this 
inoculation group. Both were culled because they became 
recumbent and unable to rise. Whilst the finding of 
hypophosphataemia in one steer may have explained the 
clinical sign of difficulty rising, the clinical presentation of 
the other steer (see Additional file 4: unconfirmed suspect, 
showing steer P90-8 with difficulty rising and standing 
motionless at the side of the pen), which was reminiscent 
of a milder form of the dull syndrome, remains unex-
plained. We previously reported the occurrence of clini-
cal signs suggestive of TSE in experimentally inoculated 
or naturally exposed farm animal species where PrPSc or 
PrPres could not be detected on examination of the brain 
by postmortem tests [32–34] and cannot exclude a similar 
phenomenon in this steer. Inoculation of mice with brain 
tissue would be required to investigate whether this steer 
developed a prion disorder that could not be confirmed 
by current statutory TSE diagnostic tests.
The brainstem samples of the nine positive cases 
inoculated with the pre-1975 pool, where the initial WB 
results resembled classical BSE, but with some differences 
regarding lower molecular mass migration and glyco-
form ratio, produced a WB profile with similarities to the 
L-type BSE control sample (see Fig. 1). On application of 
the PK susceptibility assay using mild and stringent condi-
tions the susceptibility ratio for all cases was, like L-type 
BSE, below or close to the cut off level of 0.6, compared to 
the ratio for the classical BSE control of >0.7 (see Fig. 2).
The brain samples of the seven positive cattle inocu-
lated with the post-1990 scrapie pool, the molecular 
profile of which previously resembled classical scrapie, 
maintained the classical scrapie profile with the WB pro-
tocol adapted for the detection of atypical BSE cases. 
They also exhibited variation in the molecular mass 
migration as reported previously [2]. After application of 
the PK susceptibility assay using mild and stringent con-
ditions, the susceptibility ratio showed variation between 
the cases, with five being in the range 0.6–0.8, close to 
the cut off level of <0.6 for L- or H-type BSE, and two 
being susceptible to digestion at 0.4 and 0.5.
None of the samples from the pre-1975 or the post-
1990 scrapie pools resembled an H-type BSE-like profile 
using mAbs Sha31 or P4 (no higher unglycosylated band) 
or showed the distinctive molecular mass downward shift 
and sharp band at 14  kDa, as illustrated by the H-type 
BSE control when SAF 84 was applied (see Fig. 1).
Glycoform analysis of the di- versus monoglycosylated 
bands showed that the proportion of diglycosylated PrPres 
was less than 50%, with all samples from both the pre-
1975 and the post-1990 pools clustering with the L-type 
BSE control, whereas the classical BSE control sample 
showed a clear predominance of the diglycosylated bands 
giving more than 50% signal strength (see Fig. 3). Results 
using additional characterisation techniques for C- and 
L-type BSE [10, 19] were equivocal. Although the samples 
from the both groups of scrapie-inoculated cattle exhib-
ited glycoform ratios more closely related to L-type BSE, 
previous experience has shown that ovine scrapie tends 
to have a more even distribution of the di- and mono-
glycosylated bands compared to C-type BSE (MJ Stack 
and MJ Chaplin, unpublished observation). Likewise, 
application of the PK susceptibility assay on a small num-
ber of scrapie samples has shown these samples can be 
close to the cut off point of L-type BSE (MJ Stack and MJ 
Chaplin, unpublished observation). Although these addi-
tional approaches have proven valuable in differentiating 
between bovine L- and C-type BSE [10, 19], they may not 
be reliable for differentiating WB profiles in cattle follow-
ing infection from an ovine scrapie source. However, the 
results from the vole transmissions (see below) for the 
two brain pools suggest that they are similar or identical 
to scrapie strains already isolated from other European 
natural sheep scrapie cases.
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We previously reported phenotype diversity in cattle 
inoculated with the post-1990 scrapie pool: two cat-
tle [P90-4 (inoculated into bank voles) and P90-5, see 
Table 1] presented with a molecular profile different to 
that of the other cattle in the group (see Fig. 1, lane 13 
for P90-4) which could not be explained by the number 
of octapeptide repeats in the bovine PRNP. Extended 
genotyping of the bovine PrP gene to include the pro-
moter region and full ORF further confirmed that the 
PrP genotype of the steers was not responsible for the 
differences. Although the PrP gene polymorphism 
(ORF and promoter region) of animal P90-5 was not 
found in any other steer, the genotype of P90-4 was 
identical to that of P90-2 despite having a different 
molecular mass profile. The inoculation of cattle with 
a pool of scrapie brain material, containing possibly 
multiple strains, remains the most likely reason for the 
observed diversity in the molecular profiles as hypoth-
esised previously [2]. Similarly, the PrP gene polymor-
phism did not appear to be responsible for the lack of 
transmission in some animals since the same polymor-
phism was found in inoculated cattle with or without 
Table 1 Animal details and outcome of cattle inoculated intracerebrally with two scrapie pools
ORF open reading frame of the bovine PrP gene detailing the number of N-terminal octapeptide repeats, the silent polymorphisms Q78 and N192, either homozygous 
(hom) or heterozygous (het) at position 78 and 192 of the ORF respectively compared to the wild type (WT); and the 23 and 12 bp indels (− deletion allele, + insertion 
allele) of the promoter PrP gene, mpi months post inoculation, rounded down to the nearest month.
Case ORF 23 bp 12 bp Death (mpi) Reason for cull (clinical and/or pathological diagnosis) TSE test result
Pre‑1975 pool
 P75‑1 6:6 N192 het −/− −/− 18 TSE suspect (dull syndrome) Positive
 P75‑2 6:6 Q78 het +/− +/− 21 TSE suspect (dull syndrome) Positive
 P75‑3 6:6 WT −/− −/− 24 TSE suspect (dull syndrome) Positive
 P75‑4 6:6 N192 het −/− −/− 24 TSE suspect (dull syndrome) Positive
 P75‑5 6:5 Q78 het +/− +/+ 24 TSE suspect (dull syndrome) Positive
 P75‑6 6:6 Q78 het +/− +/− 26 TSE suspect (dull syndrome) Positive
 P75‑7 6:6 WT −/− −/− 29 TSE suspect (dull syndrome) Positive
 P75‑8 6:6 WT −/− −/− 34 TSE suspect (dull syndrome) Positive
 P75‑9 6:6 Q78 het +/− +/− 56 TSE suspect (dull syndrome) Positive
 P75‑10 6:6 Q78 het +/− +/− 91 Muscle trauma Negative
Post‑1990 pool
 P90‑1 6:6 N192 het −/− −/− 18 TSE suspect (dull syndrome) Positive
 P90‑2 6:5 Q78 het +/− +/+ 24 TSE suspect (nervous syndrome) Positive
 P90‑3 6:6 Q78 het +/− +/− 25 TSE suspect (dull syndrome) Positive
 P90‑4 6:5 Q78 het +/− +/+ 30 TSE suspect (dull syndrome) Positive
 P90‑5 6:6 Q78 hom +/+ +/+ 32 TSE suspect (nervous syndrome) Positive
 P90‑6 6:6 Q78 het +/− +/− 35 TSE suspect (dull syndrome) Positive
 P90‑7 6:6 WT −/− −/− 54 TSE suspect (dull syndrome) Positive
 P90‑8 6:6 Q78 het +/− +/− 84 TSE suspect (difficulty rising, dullness) Negative
 P90‑9 6:6 Q78 het +/− +/− 99 Difficulty rising, stiffness, hypophosphataemia Negative
 P90‑10 6:6 Q78 het +/− +/− 120 End of study Negative
Saline solution
 CSa‑1 6:6 WT −/− −/− 60 Difficult to handle (cryptorchid) Negative
 CSa‑2 6:6 Q78 hom +/− +/− 101 Stiffness, visual impairment (strabismus, exophthalmos) Negative
 CSa‑3 6:6 Q78 het +/− +/− 103 Osteoarthrosis Negative
 CSa‑4 6:5 WT −/− +/− 115 Vertebral fracture Negative
 CSa‑5 6:6 Q78 het N192 het +/− +/− 120 End of study Negative
Scrapie‑free brain
 CB‑1 6:6 Q78 het +/− +/− 82 Spastic syndrome, osteoarthrosis Negative
 CB‑2 6:6 WT −/− −/− 82 Spastic syndrome, osteoarthrosis Negative
 CB‑3 6:6 Q78 het +/− +/− 120 End of study Negative
 CB‑4 6:6 Q78 het N192 het +/− +/− 120 End of study Negative
 CB‑5 6:6 WT −/− −/− 120 End of study Negative
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PrPSc accumulation in the brain (see Table  1) and all 
scrapie-inoculated cattle with no evidence of PrPSc in 
the brain were heterozygous carriers of the 12 base pair 
(bp) deletion allele, which is associated with a higher 
risk of having BSE [35].
Transmission in bank voles
Prior to inoculation the bovine donor brain samples 
were subject to molecular analyses. Low levels of PrPres 
were detectable by WB with mAb SAF84 in the inocu-
lum from P75-7, whilst PrPres was not detected in the 
Fig. 1 Discriminatory Western immunoblot of brain samples from cattle inoculated with the pre‑1975 and post‑1990 scrapie brain pools. Lanes 1–9 
cattle inoculated intracerebrally with the pre‑1975 scrapie pool: P75‑1, P75‑2, P75‑3, P75‑4, P75‑5, P75‑6, P75‑7, P75‑8 and P‑75‑9. Lanes 10–16 cattle 
inoculated intracerebrally with the post‑1990 scrapie pool: P90‑2, P90‑3, P90‑1, P90‑4, P90‑5, P90‑6 and P90‑7. Lanes L, H, C, O controls: L‑type BSE, 
H‑type BSE, classical BSE, ovine scrapie. Lanes M molecular mass marker. Animal P90‑4, sample lane 13, was an outlier with a lower molecular mass 
of the unglycosylated band with mAbs Sha31 and SAF84 compared to the other samples previously tested with mAb 6H4. The sample of the other 
outlier P90‑5 (determined previously by testing caudal medulla), sample lane 14, consisted here of rostral medulla and gave a molecular profile 
similar to the others of the group as observed in the original blot when both brain samples were tested [2]. The lane numbers of those cattle that 
provided the inocula for bank voles and mice are underlined.
Fig. 2 PK susceptibility ratio for the mild and stringent digestion conditions of samples from the pre‑1975 scrapie pool compared to BSE. Controls 
comprise a UK classical BSE (C‑type) sample (two analyses of the same sample and mean) and a UK L‑type BSE sample (two analyses of the same 
sample and mean). Detection with mAbs Sha31 and 6H4. The case that provided the inoculum for bank voles and mice is underlined.
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inoculum from P90-4 (Fig.  4). The molecular profile of 
P75-7, in terms of both molecular mass and glycoform 
ratios showed some similarity to those of BASE in cat-
tle, CH1641 and natural CH1641-like isolates in sheep. 
Accordingly, P75-7 was PrPres-negative with mAb P4 by 
discriminatory WB. Re-analysis after PrPres concentra-
tion yielded identical results for the inoculum from P75-7 
whilst very low levels of PrPres, which displayed a classi-
cal scrapie-like molecular profile (data not shown), were 
detected in the inoculum from P90-4. These findings 
were consistent with those made by separate WB analy-
sis of the bovine brainstems (see above), which indicated 
that the molecular profile was maintained within dif-
ferent brain areas regardless of the choice of antibodies 
Sha31 or SAF84.
On primary transmission in bank voles P75-7 gave a 
relatively long survival time (627 ± 72 days post inocula-
tion, dpi) and a low attack rate (7/12). The PrPres pattern 
in infected vole brains analysed by WB was not uni-
form (Fig. 5), with individual voles showing either a high 
molecular mass unglycosylated PrPres fragment (n  =  5, 
~18  kDa, classical scrapie-like) or low molecular mass 
unglycosylated PrPres fragment (n = 2, ~17 kDa, classical 
BSE-like). This partial similarity with classical BSE was 
confirmed by discriminatory WB, which showed that the 
17 kDa PrPres fragment in voles infected with P75-7 was 
poorly detected by mAb 12B2, the epitope of which (aa 
93WGQGG97) is near the N-terminus of the PrPres frag-
ment (Fig. 5).
Second and third passages were made using donor 
voles displaying either the 18 or 17  kDa PrPres frag-
ment. The survival times and attack rates are displayed in 
Table 2.
Overall, the transmission pattern observed with P75-7 
had some similarities to that observed after transmission 
of CH1641 and CH1641-like natural sources in voles, 
which in previous experiments showed long incuba-
tion time and the presence of either 18 or 17 kDa PrPres 
Fig. 3 Scattergram showing the relative glycosylation quantity analysis of brain material from cattle inoculated with the pre‑1975 and post‑1990 
scrapie pools compared to BSE and ovine scrapie controls. Detection with mAb Sha31. Controls comprised an ovine scrapie case, a classical BSE 
case (two analyses of the same sample each) and L‑type and H‑type BSE cases from the UK. The black circle indicates all 16 samples from the intrac‑
erebrally inoculated cattle clustering together around the L‑type BSE control (blue square). The cases that provided the inocula for bank voles and 
mice are underlined.
Fig. 4 Western immunoblot of bovine brain samples used for 
transmission in bank voles and comparison with BASE and scrapie. 
(1) P75‑7, (2) molecular mass marker, (3) P90‑4, (4) BASE, (5) classical 
scrapie. Detection with mAb SAF84.
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fragments after primary transmission (U Agrimi and R 
Nonno, unpublished observations). Also, the vole-adapted 
“sub-strains” derived from CH1641 gave survival times of 
~110 dpi for the 17K sub-strain and of ~140 dpi for the 
18K sub-strain (Table 2). These results differ from those 
obtained after transmission of L-type BSE (survival times 
~400 dpi on second passage [36]) and classical BSE (sur-
vival times 483 ± 85 dpi on second passage [37]) in voles.
Lesion profiles of the two vole-adapted sub-strains 
derived from P75-7 were slightly different, with the 18K 
sub-strain inducing more pronounced spongiform degen-
eration in the hippocampus and cerebral cortex compared 
to the 17K sub-strain (Fig.  6). These lesion and molecu-
lar profiles were again very similar to those obtained 
with CH1641 (Fig. 6). Although the P75-7 inoculum did 
not transmit to wild-type mice, brains from other steers 
inoculated with the pre-1975 scrapie pool transmitted to 
wild-type mice (RIII, C57Bl and VM), with a high attack 
rate in RIII mice [2], whereas CH1641 does not transmit 
to wild-type mice. Natural CH1641-like scrapie sources, 
however, produced a TSE in C57Bl mice [38], but the 
resulting lesion profile was different to that obtained from 
inoculation of C57Bl mice with brain from one pre-1975 
inoculated steer (T Konold, unpublished observation). 
We cannot exclude the possible existence of several agent 
strains in the bovine brain, particularly as the inoculum 
for cattle was a pool of scrapie brains, which may have 
been selected variably in each of the species and forms of 
host models used. Similarly, minor variables in sampling 
for different techniques and studies may have resulted in 
testing of material with differing agent content.
The inoculum P90-4 also produced a long survival time 
(382  ±  159  dpi) and an attack rate of 11/15 although, 
based on the low level of PrPres detection in the WB, this 
may have been a result of the possibly lower infectious 
titre of the inoculum. All affected vole brains had a classi-
cal scrapie-like pattern by WB (Fig. 5).
Second and third passages gave short and consistent 
survival times (100 ± 5 and 95 ± 5 dpi, respectively).
Lesion profiles of vole-adapted P90-4 were different 
from those observed in P75-7 (Fig. 6). The survival time 
Fig. 5 Western immunoblot and antibody signal ratio of vole brain 
samples after primary passage of bovine scrapie and comparison 
with vole‑adapted classical scrapie and BSE. WB analysis of PrPres 
in voles infected with P75‑7 (primary passage) compared with a 
representative sample of P90‑4 (primary passage), vole‑adapted 
classical scrapie and BSE. Replica blots were developed with mAbs 
SAF84 (upper panel) and 12B2 (lower panel) to compare the antibody 
reactivity with each sample similar to the discriminative WB used for 
samples from small ruminants. The graph on the bottom shows the 
SAF84/12B2 signal ratio relative to the scrapie control. Values higher 
than 1 denote more C‑terminal PK‑cleavage and consequential loss 
of the epitope of 12B2.
Table 2 Survival times and attack rates of bank voles after inoculation with brains from P75-7 and P90-4 and comparison 
with other isolates
Survival times are expressed in days post inoculation with standard error of the mean.
K denotes the molecular masses (in kDa) of the unglycosylated PrPres  band determined by WB.
Inoculum Survival time (attack rate)  
on primary transmission
Survival time (attack rate)  
on second passage
Survival time (attack rate)  
on third passage
P75‑7 627 ± 72 (7/12) 18K 144 ± 7 (7/7) 18K 122 ± 5 (10/10)
17K 145 ± 7 (14/14) 17K 111 ± 15 (6/6)
P90‑4 382 ± 159 (11/15) 100 ± 5 (8/8) 95 ± 5 (7/7)
CH1641 18K 147 ± 11 (8/8) 18K 139 ± 9 (13/13)
17K 112 ± 8 (10/10) 17K 119 ± 6 (10/10)
SCR6 197 ± 19 (18/18) [12] 98 ± 4 (11/11) [12] 94 ± 5 (11/11)
SS‑UK6 175 ± 18 (22/22) [12] 96 ± 4 (11/11) [12] 85 ± 4 (8/8)
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Fig. 6 Lesion profiles of vole‑adapted bovine scrapie at second and third passages and comparisons with other isolates. a Lesion profiles of 
vole‑adapted P75‑7 at second and third passages in voles in comparison with the two ‘sub‑strains’ (17 and 18K) of vole‑adapted CH1641. b Lesion 
profiles of vole‑adapted P90‑4 at second and third passages in voles in comparison with two natural scrapie isolates from sheep (SS‑UK6 and SCR6). 
Scored neuroanatomical areas: 1 medulla, 2 cerebellum, 3 superior colliculus, 4 hypothalamus, 5 thalamus, 6 hippocampus, 7 septum, 8 retrosplenial 
and adjacent motor cortex, 9 cingulate and adjacent motor cortex.
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after adaptation and the lesion profile observed with 
P90-4 were very similar to those observed in previous 
experiments after transmission in voles of several ARQ/
ARQ natural scrapie sources, including SCR6 that con-
tributed to the post-1990 pool and others from the same 
UK flock of Suffolk sheep with endemic scrapie [12]; 
see the lesion profiles displayed in Fig.  6b for compari-
son. All these isolates belong to a category provisionally 
called “It93”, so called because to date, all scrapie isolates 
from Italy and some ARQ/ARQ isolates from the UK 
have shown the same biological features (U Agrimi and R 
Nonno, unpublished observation).
In summary the findings in bank voles suggest that the 
prion strains isolated from the cattle inoculated with the 
pre-1975 and the post-1990 scrapie brain pools were dif-
ferent and distinct from classical BSE and L-type BSE, 
but similar, or identical, to scrapie strains previously iso-
lated from European natural sheep scrapie cases.
Transmissions in transgenic mice
Table  3 gives details of the transmissions in transgenic 
mice inoculated with the pre-1975 and post-1990 scrapie 
brain pools and the brain tissue from each of two cases 
of scrapie transmissions in cattle, sourced from separate 
inocula groups.
Neither of the ovine scrapie pools or inocula from 
P75-7 or P90-1 transmitted to tg001 mice on first or sec-
ond passage (Table  3). Lack of transmission of different 
Table 3 Mean survival times and attack rate in transgenic mice inoculated with two ovine scrapie pools, two single case 
sources of bovine scrapie and single case sources of classical and atypical BSE on primary and second passage
Survival times are displayed in days with standard error of the mean. K denotes the molecular masses (in kDa) of the unglycosylated PrPres  band determined by WB.
ND not done.
a Inoculum from clinical BSE suspect, 8 year-old Holstein-Friesian cow, UK.
b Inoculum from 03-2095, clinically healthy ≥8 year-old cow, France [9, 44].
c Previously published data from UK and French cases: C-type BSE (BSE2, 8 year-old Hereford crossbred cow, clinical suspect), ovine BSE (pool from 7 ARQ/ARQ sheep 
intracerebrally infected with brainstem from a naturally affected BSE cow in France) [31].
d Brain pool of ARQ/ARQ sheep inoculated with brain from a naturally infected BSE cow [26].
e One additional inoculated mouse died at 535 days but no TSE diagnosis was possible.
f Previously published data from French cases: Ovine BSE (case ARQ1), C-type BSE (case 3), L-type BSE (case 7) [29].









H-type BSE L-type BSE
BoPrP‑tg110
 1st passage 643 (1/5) 
19 + 21K
173 ± 3 (6/6)
21K
457 ± 60 (3/6) 
19K
203 ± 5 (6/6)
19K
295 ± 12 (6/6) 
BSE likea
234 ± 5 (6/6) 
BSE like
292 ± 5 (6/6) 
H‑typeb




282 ± 6 (6/6)
19K
190 ± 16 (6/6)
21K
191 ± 4 (6/6)
19K
200 ± 9 (6/6)
19K
265 ± 35 (6/6) 
BSE like
234 ± 3 (6/6) 
BSE like
296 ± 7 (6/6) 
H‑type
199 ± 1 (6/6) 
L‑type
PoPrP‑tg001
 1st passage >650 (0/6) >650 (0/6) >650 (0/6) >650 (0/6) 498 ± 9c 
(2/12)
458 ± 11c 
(15/15)
>650 (0/6)b >650 (0/6)
 2nd pas‑
sage
>650 (0/6) >650 (0/6) >650 (0/6) >650 (0/6) 198 ± 6c 
(15/15)
162 ± 4c 
(13/13)
>650 (0/6)b >650 (0/6)
MuPrP‑tga20
 1st passage 571 ± 31 (3/6)
21K
440 ± 3 (5/6) 441 ± 67 (6/6)
21K
480 ± 13 (6/6) 473 ± 24 (6/6) 
BSE like





159 ± 2 (6/6)
21K
408 ± 33 (3/6) 146 ± 41 (3/3)
21K
ND 147 ± 3 (6/6) 
BSE like




 1st passage ND >650 (0/5) ND >650 (0/6) >700 (1/12) 
BSE like
615 ± 84 (4/6) 
BSE liked




ND >650 (0/5) ND >650 (0/6) 690 ± 35 (5/6) 
BSE like
564 ± 39 (5/5) 
BSE like
>700 (0/6)b 684 ± 45 (4/4) 
L‑type
OvPrP‑tg338
 1st passage 480 ± 19 (6/6)
21K
>638 (0/6) 69 ± 1 (6/6)
21K
148 ± 2 (5/6)
19K
704 ± 36 (6/7) 
BSE likef
560 ± 60 (5/5) 
BSE‑likef
595 ± 18 (8/8) 
H‑typeg




ND 545 (1/5)e 19K ND ND ND 178 ± 2 (4/4) 
BSE‑likef
319 ± 10 (6/6) 
H‑typeg
141 ± 2 (7/7) 
BSE‑likef
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classical scrapie isolates in tg001 mice has been previ-
ously described [31]. It appears therefore that these mice 
are also resistant to infection with scrapie sourced from 
a bovine host, as they are to challenge with L-type BSE, 
and only susceptible to classical bovine and ovine BSE.
Although both original scrapie pools transmitted to 
tg338 mice, survival times were almost seven times 
shorter in mice inoculated with the pre-1975 scrapie 
pool. As both inocula produced disease in cattle with 
similar survival time ranges, it seems unlikely that this 
finding is due to a lower infectious titre in the post-1990 
scrapie pool. Short survival periods are observed in tg338 
mice (a VRQ PrP transgenic mouse line) inoculated with 
VRQ/VRQ scrapie sheep isolates, whereas longer survival 
times have been observed in tg338 mice inoculated with 
ARQ/ARQ scrapie sheep isolates [39]. Both pools con-
tained brains from VRQ/VRQ, ARQ/VRQ and ARQ/ARQ 
sheep in similar proportions (J Foster, personal commu-
nication). It is more likely that the post-1990 brain pool 
contained isolates which have been shown not to propa-
gate in wild-type mice but transmit to tg338 mice with 
similar long incubation periods regardless of genotype of 
the sheep (VRQ/VRQ or ARQ/ARQ) source [40]. In fact, 
the post-1990 scrapie pool did transmit poorly to wild-
type mice [2], and historical transmission studies using 
some of the individual sheep brains that made up the 
pool showed that one isolate (SCR 6) did not transmit or 
had a low transmission rate in wild-type mice whilst oth-
ers (SCR 4, 9-11) transmitted well ([41]; J Foster, personal 
communication).
The survival times in tg338 mice inoculated with the 
inoculum from P75-7 were more than three times shorter 
than with inocula from ovine or bovine BSE sources. By 
contrast, the inoculum from P90-1 failed to transmit at 
primary passage but transmitted weakly on second pas-
sage; a phenomenon, which has not previously been 
documented for any isolate from naturally infected cattle 
with TSEs in this mouse line.
None of the WB profiles obtained after passage in 
tg110 mice resembled classical BSE. The profile in mice 
inoculated with the pre-1975 pool and P75-7 inoculum 
showed an unglycosylated band of 19  kDa, which was 
maintained after passage in all tg110 inoculated with 
this inoculum (see Fig.  7). This profile was reminiscent 
of CH1641, supported by the results in bank voles, which 
suggests that CH1641 was present in the pre-1975 scra-
pie pool, but this profile also resembled L-type BSE, like 
the WB profile of brain from steer P75-7, which pro-
vided the inoculum. A similar, L-type BSE-like WB pro-
file has also been observed in tg110 mice inoculated with 
Fig. 7 Western immunoblot profiles of tg110 mice inoculated with original scrapie brain pools and bovine scrapie sources P90‑1 and P75‑7. Lanes 
on top blot. 1 and 14 Molecular mass marker (kDa). 2 Post‑1990 scrapie brain pool. 3 Post‑1990 scrapie brain pool in Tg110 mice (first passage). 4 
Post‑1990 scrapie brain pool in Tg110 mice (second passage). 5 P90‑1. 6 P90‑1 in Tg110 mice (first passage). 7 Pre‑1975 scrapie brain pool. 8 Pre‑1975 
scrapie brain pool in Tg110 mice (first passage). 9 Pre‑1975 scrapie brain pool in Tg110 mice (second passage). 10 P75‑7. 11 P75‑7 in Tg110 mice (first 
passage). 12 Negative control (brain from non‑inoculated Tg110 mice). 13 Positive control (brain from tg110 mice inoculated with classical BSE: case 
VLA‑PG817/00). Antibody: Sha31. The molecular profile of the original post‑1990 scrapie brain pool is maintained after passage in Tg110 mice (lanes 
2–4) but does not resemble the profile of P90‑1 or the mice inoculated with P90‑1 brain (lanes 5, 6). By contrast, the profile of the original pre‑1975 
brain pool (lane 7) differed from the profile obtained from inoculated Tg110 mice (lanes 8, 9), P75‑7 (lane 10) and the mice inoculated with P75‑7 
brain, which were all similar. The profiles obtained in individual mice after inoculation with the steers’ brains were identical within each inoculation 
group (bottom blot).
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numerous non-CH1641 sheep and goat scrapie isolates 
from different European countries including France, UK, 
and Spain ([42]; JM Torres, unpublished data). Despite its 
resemblance to L-type BSE, the lesion profile and PrPSc 
distribution in the brain of tg110 mice was different to 
L-type BSE and as reported for CH1641 [43]. Another 
characteristic that distinguishes this isolate from L-type 
BSE was the lack of transmission in human-PrP trans-
genic mice (tg340) (Table 3). Furthermore, interpretation 
of the persistence of this molecular profile is also made 
difficult by the fact that the BASE or L-type BSE strain 
has been shown to convert into a classical BSE strain 
upon second passage in wild-type mice [8], although it 
maintained the L-type BSE-like profile in mice expressing 
the bovine PrP gene (Tg540 mouse line) [29]. Indeed, the 
majority of classical BSE cases that have been observed 
and examined with the necessary molecular detail were 
most likely the result of recycling of an agent within the 
cattle population, via meat and bone meal [45].
The WB profile obtained after inoculation of tg110 
mice with the inoculum from P90-1 gave an unglyco-
sylated 21 kDa band that has also been observed in tg110 
mice inoculated with some sources of classical scrapie 
(JM Torres, unpublished data). A WB profile with an 
unglycosylated band of 19  kDa (L-type BSE-like) was 
also obtained after inoculation of tg110 mice with the 
post-1990 scrapie brain pool but the profiles obtained 
from the brain of steer P90-1 and tg110 mice inocu-
lated with the inoculum from P90-1 were different (ung-
lycosylated band of 21  kDa, in Fig.  7). It is not known 
whether the different infectious dose of the inoculum 
(1 ml of 10% in cattle versus 20 µl of 2% homogenate in 
mice), which is reflected in the attack rate (7/10 in cat-
tle versus 1/5 in mice), contributed in any respect to this 
finding.
Conclusions
Two different disease phenotypes were produced after 
intracerebral inoculation of cattle with scrapie brain 
pools sourced pre-1975 and post-1990 in GB, which were 
not readily explained by any differences in PrP geno-
type of the cattle. Based on pathological and molecular 
characteristics and biological characterisation in bank 
voles and transgenic mice there was no clear evidence of 
an agent derived from the cattle resembling classical or 
atypical forms of BSE. Transmissions in bank voles iden-
tified previously isolated scrapie strains and some simi-
larities to the experimental isolate CH1641. Contrary to 
the transmission results in rodents, the results for the 
molecular techniques, which have been adopted for the 
detection of atypical BSE cases, suggest that they may not 
be appropriate for differentiating WB profiles in cattle 
following infection from an ovine scrapie source.
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Additional file 1: Summary of original experiment. This document 
gives an overview of the inoculations carried out in cattle and wild‑type 
mice with references to the animal numbers in the original, published 
study [2]. 
Additional file 2: Nervous syndrome. Steer P90‑2 presenting with 
the nervous syndrome at 24 months after intracerebral inoculation 
with the post‑1990 scrapie pool; TSE confirmed by postmortem tests. 
This steer displays an abnormal rising behaviour (attempt to rise on its 
fore limbs first when disturbed by a pen mate). Examination in a crush 
reveals over‑reactivity to visual (menace response testing) and tactile 
facial stimuli (testing of sensation by touch with artery forceps) as 
well as tremor of the shoulder muscles. It is reluctant to walk towards 
the end of the corridor, seemingly apprehensive of the drain cover 
and groove on the floor, which it does not want to cross. There is mild 
hind limb ataxia as the steer walks away. Back in the pen, the steer is 
apprehensive of the approaching hand, tossing its head and wrinkling 
its nose before backing off, unlike the other steers in the pen, which 
appear curious. 
Additional file 3: Dull syndrome. Steer P75‑1 presenting with the dull 
syndrome at 18 months after intracerebral inoculation with the pre‑1975 
scrapie pool; TSE confirmed by postmortem tests. Initially, the clip shows 
two events of difficulty rising (the steer is briefly marked by an orange 
arrow to distinguish it from one of its pen mates). Dull demeanour is 
displayed on three separate occasions on the same day: the steer stands 
with its head between the wall and ladder in the pen, also temporarily 
resting its head on the ladder, for approximately two minutes (indicated 
by the counter on the top left corner of the clip). It also stands motionless 
with its head in the corner of the pen or in the gap between the wall and 
the pen divider. Loss of balance is evident during a neurological examina‑
tion carried out two days later. The signs were suggestive of a diffuse or 
multifocal brain disease. 
Additional file 4: Unconfirmed suspect. This clip shows steer P90‑8 at 
82–83 months after intracerebral inoculation with the post‑1990 scrapie 
pool; TSE not confirmed by postmortem tests. Closed circuit television 
(time lapse VHS video recording in black and white, two cameras per pen 
marked 1 and 2) shows this animal (marked briefly with an orange circle 
or arrow to distinguish it from its pen mate) having difficulty rising (rock‑
ing several times, before rising on its fore limbs) and here shown on two 
occasions on separate days. After one of these episodes it walks along the 
pen divider and stands motionless with its head in the gap between the 
wall and the pen divider for almost two minutes (indicated by the counter 
on the right bottom corner of the clip), as seen in previous cases display‑
ing the “dull” syndrome. The steer was culled one month later when it was 
found recumbent and unable to get up unaided.
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